European Parliament 25 October 2002, WRITTEN QUESTION E-3071/02 by Roberta Angelilli (UEN) to the Commission. Special Commissioner for Traffic for the city of Rome.
Also known as
European Union · · · 12-06-2003
Answer given by Mr Liikanen on behalf of the Commission (12 November 2002) Letigen is a medicinal product which contains 20 miligram (mg) ephedrine and 200 mg coffein. No divergent decision have been taken by national authorities for Letigen because a marketing authorisation was only requested by an applicant in Denmark.
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit